| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.06 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.08 | 0.07 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |